Regents of the University of California’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,366
| Closed | -$692K | – | 33 |
|
|
2022
Q4 | $692K | Sell |
4,366
-10,442
| -71% | -$1.65M | 0.13% | 20 |
|
|
2022
Q3 | $2.85M | Sell |
14,808
-40,644
| -73% | -$7.82M | 0.58% | 9 |
|
|
2022
Q2 | $8.1M | Hold |
55,452
| – | – | 1.62% | 6 |
|
|
2022
Q1 | $9.76M | Hold |
55,452
| – | – | 1.47% | 6 |
|
|
2021
Q4 | $16.3M | Sell |
55,452
-20,631
| -27% | -$6.06M | 2.28% | 5 |
|
|
2021
Q3 | $18.9M | Sell |
76,083
-21,741
| -22% | -$5.4M | 2.23% | 6 |
|
|
2021
Q2 | $24.9M | Sell |
97,824
-27,176
| -22% | -$6.91M | 3.18% | 3 |
|
|
2021
Q1 | $22.2M | Sell |
125,000
-15,280
| -11% | -$2.71M | 2.89% | 4 |
|
|
2020
Q4 | $22.2M | Sell |
140,280
-32,308
| -19% | -$5.1M | 3.2% | 4 |
|
|
2020
Q3 | $44.5M | Sell |
172,588
-23,942
| -12% | -$6.17M | 6.18% | 3 |
|
|
2020
Q2 | $45.6M | Buy |
+196,530
| New | +$45.6M | 6.4% | 3 |
|